Avalo Therapeutics, Inc. (AVTX)
Avalo Therapeutics, Inc. (AVTX) Insider Trading
Directors, officers and holders of more than 10% of AVTX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 170 transactions on file: 0 with code P, 12 with code S and 38 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Jain Rita | Director | A Award | 1,322 | $12.29 | $16,247 |
| Sep 30, 2026 | Philip Ron M | Director | A Award | 1,109 | $12.29 | $13,630 |
| Sep 30, 2026 | Lind Kevin Robert | Director | A Award | 1,352 | $12.29 | $16,616 |
| Sep 16, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 12,394 | Not measured | Not measured |
| Sep 16, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 12,394 | $9.88 | $122,453 |
| Sep 16, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 12,394 | $16.33 | $202,437 |
| Sep 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 10,185 | $17.62 | $179,457 |
| Sep 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 10,185 | Not measured | Not measured |
| Sep 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 10,185 | $8.04 | $81,887 |
| Aug 28, 2026 | Doyle Mittie | Chief Medical Officer | S Sale | 679 | $20.00 | $13,580 |
| Aug 28, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 679 | Not measured | Not measured |
| Aug 28, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 679 | $8.04 | $5,459 |
| Aug 18, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 31,031 | Not measured | Not measured |
| Aug 18, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 31,031 | $20.05 | $622,324 |
| Aug 18, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 31,031 | $9.88 | $306,586 |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 37,945 | $19.85 | $753,333 |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 37,945 | $9.88 | $374,897 |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2,876 | $9.88 | $28,415 |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 2,876 | Not measured | Not measured |
| Aug 17, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,000 | Not measured | Not measured |
| Aug 17, 2026 | Doyle Mittie | Chief Medical Officer | S Sale | 1,000 | $20.00 | $20,000 |
| Aug 17, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,000 | $12.65 | $12,650 |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | S Sale | 3,749 | $19.94 | $74,762 |
| Aug 17, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | M Exercise | 37,945 | Not measured | Not measured |
| Aug 11, 2026 | Riley Jennifer | Chief Strategy Officer | S Sale | 2,655 | $19.59 | $52,012 |
| Aug 10, 2026 | Doyle Mittie | Chief Medical Officer | S Sale | 679 | $20.00 | $13,580 |
| Aug 10, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 679 | $8.04 | $5,459 |
| Aug 10, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 679 | Not measured | Not measured |
| Jul 27, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,000 | $12.65 | $12,650 |
| Jul 27, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,000 | Not measured | Not measured |
| Jul 27, 2026 | Doyle Mittie | Chief Medical Officer | S Sale | 1,000 | $20.00 | $20,000 |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 2,875 | $12.65 | $36,369 |
| Jun 30, 2026 | Lind Kevin Robert | Director | A Award | 1,105 | $15.04 | $16,619 |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,779 | $8.04 | $14,303 |
| Jun 30, 2026 | Jain Rita | Director | A Award | 1,080 | $15.04 | $16,243 |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 2,875 | Not measured | Not measured |
| Jun 30, 2026 | Philip Ron M | Director | A Award | 69 | $15.04 | $1,038 |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,779 | Not measured | Not measured |
| Jun 30, 2026 | Doyle Mittie | Chief Medical Officer | S Sale | 4,654 | $20.00 | $93,080 |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,450 | $8.04 | $11,658 |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | S Sale | 1,450 | $18.00 | $26,100 |
| Jun 23, 2026 | Philip Ron M | Director | A Award | 40,200 | Not measured | Not measured |
| Jun 23, 2026 | Doyle Mittie | Chief Medical Officer | M Exercise | 1,450 | Not measured | Not measured |
| Jun 10, 2026 | VARKI PAUL | Chief Legal Officer | F Tax Payment | 1,081 | $13.10 | $14,161 |
| Jun 10, 2026 | Doyle Mittie | Chief Medical Officer | F Tax Payment | 1,084 | $13.10 | $14,200 |
| Jun 10, 2026 | Sullivan Christopher Ryan | Chief Financial Officer | F Tax Payment | 138 | $13.10 | $1,808 |
| Jun 10, 2026 | Riley Jennifer | Chief Strategy Officer | F Tax Payment | 588 | $13.10 | $7,703 |
| Jun 2, 2026 | Heffernan Michael Thomas | Director | A Award | 29,500 | Not measured | Not measured |
| Jun 2, 2026 | KANTOFF AARON | Director | A Award | 20,100 | Not measured | Not measured |
| Jun 2, 2026 | Lind Kevin Robert | Director | A Award | 20,100 | Not measured | Not measured |
The full Form 4 history is on the AVTX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.